Evidence map›Paper›PMID 34272436›Full record

ArticleScientific reports2021

Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation.

M I Rizzo, L Tomao, S Tedesco, M Cajozzo, M Esposito, C De Stefanis, A M Ferranti, D Mezzogori, A Palmieri, G Pozzato and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Stem Cell-Based Tissue Engineering for Cleft Defects: Systematic Review and Meta-Analysis.The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2024
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

M I Rizzo *Plastic and Maxillofacial Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
L Tomao *Department of Pediatric Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
S TedescoTelea Biotech e Telea Electronic Engineering, Sandrigo, VI, Italy.
M CajozzoPlastic and Maxillofacial Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
M EspositoPlastic and Maxillofacial Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
C De StefanisResearch Laboratories, Histology Core Facility, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
A M FerrantiDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
D MezzogoriDepartment of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
A PalmieriDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, National Institute of Health, Rome, Italy.
G PozzatoTelea Biotech e Telea Electronic Engineering, Sandrigo, VI, Italy.
M AlgeriDepartment of Pediatric Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
F Locatelli *Department of Pediatric Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
L Leone *Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy. lucia.leone@unicatt.it.
M Zama *Plastic and Maxillofacial Surgery Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Bambino Gesù Children's Hospital · ITUniversità Cattolica del Sacro Cuore · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cleft lip and palate (CL/P) is the most prevalent craniofacial birth defect in humans. None of the surgical procedures currently used for CL/P repair lead to definitive correction of hard palate bone interruption. Advances in tissue engineering and regenerative medicine aim to develop new strategies to restore palatal bone interruption by using tissue or organ-decellularized bioscaffolds seeded with host cells. Aim of this study was to set up a new natural scaffold deriving from a decellularized porcine mucoperiosteum, engineered by an innovative micro-perforation procedure based on Quantum Molecular Resonance (QMR) and then subjected to in vitro recellularization with human bone marrow-derived mesenchymal stem cells (hBM-MSCs). Our results demonstrated the efficiency of decellularization treatment gaining a natural, non-immunogenic scaffold with preserved collagen microenvironment that displays a favorable support to hMSC engraftment, spreading and differentiation. Ultrastructural analysis showed that the micro-perforation procedure preserved the collagen mesh, increasing the osteoinductive potential for mesenchymal precursor cells. In conclusion, we developed a novel tissue engineering protocol to obtain a non-immunogenic mucoperiosteal scaffold suitable for allogenic transplantation and CL/P repair. The innovative micro-perforation procedure improving hMSC osteogenic differentiation potentially impacts for enhanced palatal bone regeneration leading to future clinical applications in humans.

Indexed as

Tissue ScaffoldsAnimalsBone RegenerationCell DifferentiationCellular MicroenvironmentCleft LipCleft PalateCollagen Type ICollagen Type I, alpha 1 ChainHumansMesenchymal Stem CellsOsteogenesisOsteonectinRegenerative MedicineSOXB1 Transcription FactorsSwineCollagen Type ICollagen Type I, alpha 1 ChainOsteonectinSOX2 protein, humanSOXB1 Transcription FactorsSPARC protein, human

Identifiers

PMID34272436
PMCPMC8285425
OpenAlexW3182007161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.